DSM's fourth-quarter net profit down 75% despite higher sales

DSM's fourth-quarter 2012 net profit fell by 75%, to €21 million ($28 million), compared with the €85 million reported in the fourth quarter a year earlier, the company said today. Ebitda was also down 17%,  to €243 million. Net sales went up marginally from €2.23 billion during the last quarter of 2011, to €2.27 billion during the same period last year—about a 2% increase. In DSM's life sciences division, the nutrition business contributed just over 40% of total sales, reporting €923 million, compared with €865...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers